Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.
Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, Morton JM, Leslie DB, Brancatisano R, Kow L, O'Rourke RW, Deveney C, Takata M, Miller CJ, Knudson MB, Tweden KS, Shikora SA, Sarr MG, Billington CJ.
Ikramuddin S, et al. Among authors: maher jw.
JAMA. 2014 Sep 3;312(9):915-22. doi: 10.1001/jama.2014.10540.
JAMA. 2014.
PMID: 25182100
Clinical Trial.